File:Swine flu story.ppt

Swine_flu_story.ppt ‎(file size: 1.64 MB, MIME type: application/zip)

Warning: This file type may contain malicious code. By executing it, your system may be compromised.

This page is a lecture. The page identifier is Op_en4942
Moderator:Mikko Pohjola (see all)

Upload data

Contains a draft of an introductory overview to the Finnish swine flu case

Different aspects on the media content

What is discussed? Contents, discourses, meanings.
Who talks? Whose point of view is presented? How are issues framed? Interaction settings?
How do people talk? Argumentation, rhetoric methods, use of language, prejudices...

E.g. How is swine flu or authority, citizen or expert knowledge constructed? What meanings are communicated? In what ways?

Important aspects in narcolepsy news

Development of narcolepsy assessment

Spring 2010 Neurologists surprised about # of new narcolepsy cases.
June 2010 Neurologists contact THL about their findings.
18.8.2010 The MPA (Sweden) investigates reports of narcolepsy in patients vaccinated with Pandemrix MPA [1]
18.8.2010 Expert: Unlikely that H1N1 vaccine and narcolepsy have connection YLE [2]
18.8.2010 THL will study the connection. Vaccine and narcolepsy experts will meet in the afternoon to design the study. YLE
19.8.2010 The study has been started. It will last for months. THL [3]
24.8.2010 THL recommends to stop Pandemrix vaccination. THL [4]
27.8.2010 European Medicines Agency starts review of Pandemrix EMA [5] YLE [6]
23.9.2010 EMA: Evidence insufficient to determine causal link. Pandemrix benefits larger than risks. EMA [7]

Development of narcolepsy assessment (2/2)

8.9.2010 Swedish study shows no connection between vaccination and narcolepsy MTV3 [8]
17.11.2010 Ties Between Big Pharma and THL Draw Complaints YLE [9]
30.1.2011 Swine flu faccination to children maybe a mistake YLE [10]
31.1.2011 First assessment report published by THL [11]
1.2.2011 THL: Pandemrix vaccine increased the risk of narcolepsy YLE [12]
18.2.2011 EMA: Causal relationship not established EMA [13]
August 2011: Final assessment report will be published by THL

Scope of participation, referring to who are allowed to participate in the process.
Access to information, referring to what information regarding the issue at hand is made available to participants.
Timing of openness, referring to when participants are invited or allowed to participate.
Scope of contribution, referring to which aspects of the issue at hand participants are invited or allowed to contribute to.
Impact of contribution, referring to what extent are participant contributions allowed to have influence on the outcomes, i.e. how much weight is given to participant contributions.

References

Click on a date/time to view the file as it appeared at that time.

	Date/Time	Dimensions	User	Comment
current	10:57, 24 October 2011	(1.64 MB)	Jouni (talk \| contribs)	A new version, presented in CII for MSc students, 24 Oct 2011. Contains results from the Darm course assessment (but not much from the final THL report published in September 1, 2011).
	08:49, 31 March 2011	(1.43 MB)	Jouni (talk \| contribs)	Minor changes
	06:54, 31 March 2011	(1.37 MB)	Jouni (talk \| contribs)	Previous version was corrupted, so replaced. In addition, five dimensions of openness were added.
	05:00, 31 March 2011	(1.34 MB)	Jouni (talk \| contribs)	Slides about narcolepsy assessment added
	07:20, 28 February 2011	(1.3 MB)	Mikko Pohjola (talk \| contribs)	Just some small edits.
	17:00, 27 February 2011	(1.57 MB)	Mikko Pohjola (talk \| contribs)	Contains a draft of an introductory overview to the Finnish swine flu case

There are no pages that link to this file.